FRESENIUS SE & CO. KGAA - DE0005785604 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
40
0
40
41,93 EUR
|
-0,3801% |
25.07.2025 17:32
|
- |
- |
- |
- |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
0
1
1
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
0
0
0
|
Fresenius SE & Co. KGaA
Else-Kröner-Strasse 1
61352, Bad Homburg, DE
|
| Phone |
+49-6172-608-0 |
| Fax |
+49-6172-608-2628 |
| Email |
pr-fre@fresenius.com |
| Internet |
http://www.fresenius.de
|
| IR Contact/PR Contact |
Frau Bechtold/Herr Oliver Heieck |
| Symbol |
FRE |
| End of financial year |
31.12.2025 |
| Issued capital |
23.661.586.370,00 EUR |
/IBT-BA-HP/WEB-INF/snippets/root/company/contact.jsp
65
0
65
| Freefloat |
54,17% |
| Else Kröner-Fresenius-Stiftung |
26,96% |
| Fidelity Management & Research Co. LLC |
4,52% |
| Harris Associates LP |
2,99% |
| The Vanguard Group, Inc. |
2,68% |
| Norges Bank Investment Management |
2,22% |
| DWS Investment GmbH |
1,68% |
| BlackRock Fund Advisors |
1,59% |
| Deka Investment GmbH |
1,14% |
| Capital International Ltd. |
1,10% |
| Eleva Capital SAS |
0,95% |
/IBT-BA-HP/WEB-INF/snippets/root/company/shareholders.jsp
37
0
37
| Michael Sen |
Chairman of Managing Board |
| Sara Lisa Hennicken |
Member of Executive Committee |
| Robert Möller |
Member of Executive Committee |
| Pierluigi Antonelli |
Member of Executive Committee |
| Dr. Michael Moser |
Member of Executive Committee |
| Wolfgang Kirsch |
Chairman of Supervisory Board |
| Michael Diekmann |
Member of Supervisory Board |
| Oscar Romero de Paco |
Member of Supervisory Board |
| Susanne Zeidler |
Member of Supervisory Board |
| Tania Campana |
Member of Supervisory Board |
| Holger Michel |
Member of Supervisory Board |
| Grit Genster |
Member of Supervisory Board |
| Carsten Georg |
Member of Supervisory Board |
| Bernd Behlert |
Member of Supervisory Board |
| Dr. Ralf Kiesslich |
Member of Supervisory Board |
| Dr. Christoph Zindel |
Member of Supervisory Board |
| Dr. Iris Löw-Friedrich |
Member of Supervisory Board |
/IBT-BA-HP/WEB-INF/snippets/root/company/board.jsp
40
1
41
|
Activity Description
|
|
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
|
/IBT-BA-HP/WEB-INF/snippets/root/company/corporateactions.jsp
39
0
39
